Detail akcie Kamada Ltd online

Business Summary: Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Kamada Ltd revenues increased 18% to $80.2M. Net income increased from $3K to $6.8M. Revenues reflect Proprietary Products segment increase of 33% to $72.9M, U.S.A segment increase of 76% to $55.2M, Canada segment increase of 4% to $5.8M. Net income benefited from Selling and marketing Expenses - Bal decrease of 40% to $4.2M (expense), Other expenses decrease from $1.1M (expense) to $0K.